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Abstract: The objective of this study was to examine the in vitro cytotoxic activities of Salvia officinalis (sage) oil on human immortalized
keratinocyte (HaCaT) cell lines by using an [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide] (MTT) cytotoxicity assay
after the Salvia officinalis oil administration in different doses and time-points. In vitro cytotoxic activities of Salvia officinalis oil on
HaCaT cell lines were assessed, and MTT assays were used to determine cell viability. The HaCaT cells (100 µL) were cultured in 96well plates at 2 × 104 cells per well and treated with different concentrations of Salvia officinalis oil (25 µM, 50 µM, 100 µM, 150 µM,
and 200 µM) for durations of 24, 48, and 72 h. Cell death was determined by collecting and staining with 0.4% Trypan blue for 5 min
at room temperature before microscopic examination. At 24 h, there was a significant difference between the 25 and 200 µM doses (P
= 0.034). For the 72 h Salvia officinalis oil application, there was a significant difference between the 50 and 200 µM doses only (P =
0.002). On the other hand, for 48 h Salvia officinalis application, there were significant differences between 25 and 150 µM, 25 and 200
µM, 50 and 150 µM, 50 and 200 µM, 100 and 150 µM, and 100 and 200 µM doses (P = 0.003, P = 0.000, P = 0.005, P = 0.001, P = 0.028,
and P = 0.003, respectively). We concluded that Salvia officinalis oil may help the living organism to have a healthy digestive system by
stopping excessive cell proliferation via the apoptotic pathway in the gastrointestinal system and, thus, may be used in both animal feed
and human nutrition.
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1. Introduction:
The therapeutic significance of plants is well known.
This can lead us to look for a new natural compound
for preventing some cellular processes [1,2]. Natural
plant products are used as alternative or complementary
modalities by people or animals all over the world, and this
is an increasing trend [3–5]. Salvia officinalis, which has
been cultivated since ancient times and known as sage, is a
native aromatic perennial plant [6]. Pharmacologic studies
have reported that it contains various types of secondary
metabolites, including alpha and beta thujones, flavonoids,
and phenolic acids [7,8]. Compared to other species of
Salvia, Salvia officinalis contains the highest amount of
essential oils (1–2.8%) [9]. The current literature has
proven that this plant has antimicrobial, antioxidant,
hypoglycemic, antidiabetic, antiinflammatory, and
anticancer properties. Additionally, due to their intense
antioxidant activity [10,11], these polyphenols are useful
not only for combating several degenerative diseases
including Alzheimer’s and various cellular processes
[12–17] but also helpful as dietary supplements in animal

nutrition [18]. In studies in which Salvia officinalis was
used as a dietary supplement, several features such as
having the highest activity of glutathione peroxidase in
the liver, reducing the side effects of oxidative processes
in the duodenal mucosa due to beneficial effect on the
glutathione peroxidase activity and adjustment of lipid
peroxidation in the kidney tissue, have been demonstrated
[10,11,19,20].
On the other hand, human immortalized keratinocyte
(HaCaT) cells have been widely used to study the
epidermal homeostasis and its pathophysiology, especially
in chronic inflammatory skin diseases such as psoriasis
[21,22]. Polyphenols in Salvia officinalis are in contact
with some immunological agents to cope with oxidative
stress and inflammation. They scavenge oxygen radicals
such as peroxide, hydroperoxides, or lipid peroxyl,
consequently inhibiting the oxidative stress and affecting
the T-helper cell cytokines to prevent inflammation
[23,24]. Furthermore, they are involved in a number of
cellular signaling pathways such as mitogen-activated
protein kinase, phosphatidylinositol 3-kinase/Akt, and
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tumor necrosis factor-related apoptosis-inducing ligand.
They also affect cell proliferation, differentiation, and
regulation steps and cause expression of some agents and
modulation of cellular events [6,25].
The purpose of this study was to investigate the in
vitro cytotoxic effects of Salvia officinalis oil on HaCaT
cell lines by using an [3-(4,5-dimethylthiazol-2-yl)-2,5diphenyltetrazoliumbromide] (MTT) cytotoxicity assay
after administering Salvia officinalis oil in different doses
and at different time points.
2. Materials and methods
2.1. Plant material
The harvesting of Salvia officinalis was done from
spontaneously growing samples found in middle Anatolia.
The sample collection was done in May 2016, and sample
identification was made by the Department of Aromatic
and Medicinal Plants Research, National Institute of
Agricultural and Food Technology (INIA) (Erzurum,
Turkey). A sample was stored at the INIA for internal
control. Samples were dried and kept in an oven heated to
35 °C to prevent climatic influences until analysis.
2.2. Extraction process
A 100 g sample was used for essential oil extraction.
The oil was obtained by hydrodistillation of the dried
ground material in a Clevenger-like apparatus for 2 h
at atmospheric pressure. Time was measured starting
with the falling of the first drop of the distillate. Two
replications were performed for the process. The weight of
the essential oil yield was measured. The effects of Salvia
officinalis at varying concentrations (25, 50, 100, 150, and
200 μM) and at various time points (24, 48, and 72 h) on
the proliferation of HaCaT cells were determined using
the MTT assay.
2.3. Cell culture
The nontumorigenic HaCaT cell line was acquired from
the Cell Culture and Biological Resources Unit at Yeditepe
University. These cells were seeded at a concentration of
5.000 cell/well on 96-well plate (BIOFIL, TPC, Switzerland)
and conserved in RPMI-1640 medium (Sigma Chemical
Co., St. Louis, MO, USA), which included HEPES (Sigma)
buffer along with 10% heat-inactivated fetal bovine serum
(Hyclone Lab., Logan, UT, USA), 100-μg/mL streptomycin
(Sigma), and 100-U/mL penicillin (Sigma). These were
incubated in disposable plastic tissue culture flasks in a
5% CO2/95% air incubator at 37 °C. After incubation, the
culture media were removed; the cells were washed with
PBS and MTT cell proliferation assay was performed.
2.4. Cell viability (MTT) assay
MTT assays were used to determine cell viability. The
HaCaT cells (100 µL) were cultured in 96-well plates at 2 ×
104 cells per well and treated with different concentrations

of Salvia officinalis oil (Group 1: 25 µM; Group 2: 50 µM;
Group 3: 100 µM; Group 4: 150 µM; and Group 4: 200 µM)
for durations of 24, 48, and 72 h. Following treatment,
each well was filled with 10 µL of MTT reagent (5 mg/
mL) and incubated for 4 h at 37 oC. The medium was then
eliminated and 150 µL of DMSO was added to make the
MTT formazan soluble. The absorbance of solubilized
MTT formazan products was measured by an ELISA plate
reader (Biotek, USA) at 590 nm at 24, 48, and 72 h.
Cell death was determined by collecting and staining
with 0.4% of Trypan blue for 5 m at room temperature
before microscopic examination. Viable cells were counted
via Trypan blue exclusion. Dead cells that stained blue
were deemed positive and summed against the total.
2.5. Statistical analysis
Statistical Package for the Social Sciences SPSS version
22 (IBM Corp., Armonk, NY, USA) was used for data
analysis. As descriptive statistics, numerical variables were
summarized as mean (± standard deviation). Comparisons
between the groups were made with the one-way ANOVA
test. A P-value below 0.05 was considered as statistically
significant.
3. Results
The kinetic study revealed that Salvia officinalis inhibits cell
growth in a dose- and time-dependent way in the HaCaT
cells. Cell viability decreased in all Salvia officinalis oil
doses, and the high cytotoxic dose was 200 μM for all time
points. On the other hand, Salvia officinalis oil showed its
effect with minimum cytotoxicity for 72 h in all doses on
HaCaT cells. The Figure and Table 1 show the mean values
of cell viability in all experimental groups with standard
deviations.
After the statistical analyses were performed, it was
seen that there were significant differences between
groups concerning the dose intervals and time points. For
24-h Salvia officinalis application, there was a significant
difference between the 25 and 200 µM doses (P = 0.034).
For the 72-h Salvia officinalis application, there was a
significant difference between only 50 and 200 µM doses
(P = 0.002). On the other hand, for 48-h Salvia officinalis
oil application, there were significant differences between
the 25 and 150 µM, 25 and 200 µM, 50 and 150 µM, 50
and 200 µM, 100 and 150 µM, and 100 and 200 µM doses
(P = 0.003, P = 0.000, P = 0.005, P = 0.001, P = 0.028, and
P = 0.003, respectively). The significance (P) values of all
variables are given in Table 2.
4. Discussion
In this study, we examined the impact of Salvia officinalis
oil on the cell viability of human HaCaT keratinocytes.
When the literature was checked regarding the effects of
Salvia officinalis oil on HaCaT keratinocyte cells, no it
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Figure: Results for the mean values of cell viability in all experimental groups by using
the MTT assay. MTT: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide.
Group 1: treated with 25 µM Salvia officinalis oil; Group 2: treated with 50 µM Salvia
officinalis oil; Group 3: treated with 100 µM Salvia officinalis oil; Group 4: treated with
150 µM Salvia officinalis oil; Group 5: treated with 200 µM Salvia officinalis oil.
Table 1: Mean values and standard deviations of all experimental groups.
Groups Group 1
(25 µM)

Group 2
(50 µM)

Group 3
(100 µM)

Group 4
(150 µM)

Group 5
(200 µM)

Time of
measurement
24 h

Mean ± SD

Mean ± SD

Mean ± SD

Mean ± SD

Mean ± SD

0.075 ± 0.004

0.073 ± 0.002

0.072 ± 0.005

0.071 ± 0.005

0.062 ± 0.008

48 h

0.053 ± 0.008

0.050 ± 0.005

0.047 ± 0.004

0.031 ± 0.005

0.026 ± 0.005

72 h

0.158 ± 0.008

0.185 ± 0.032

0.148 ± 0.013

0.152 ± 0.019

0.112 ± 0.024

Group 1: treated with 25 µM Salvia officinalis oil; Group 2: treated with 50 µM Salvia officinalis oil; Group 3: treated with
100 µM Salvia officinalis oil; Group 4: treated with 150 µM Salvia officinalis oil; Group 5: treated with 200 µM Salvia
officinalis oil.

was determined that no previous scientific studies had
been performed on HaCaT cells; however, there have been
some studies carried out on the role of Salvia officinalis
in preventing chronic inflammation [26,27]. If any natural
compounds have inhibitory features on the proliferation
and modulation of keratinocyte differentiation, they may
be beneficial for the treatment of psoriasis by controlling
keratinocyte growth. According to our findings, Salvia
officinalis could significantly suppress the proliferation of
HaCaT cell line in vitro employing the MTT assay. Such
antiproliferative activity of Salvia officinalis oil was reported
in Jiang et al.’s study [6]. They applied Salvia officinalis
on HepG2 liver carcinoma cells and demonstrated the
cytotoxic, antioxidant, and antiproliferative effects on
cancer cells in a time- and dose-dependent manner.
It is well established that epidermal keratinocyte
hyperproliferation results from the abnormal expression
of several regulatory molecules related to proliferation
such as IFNγ, IL-4, IL-17A, and IL-22. Apoptotic defects
are thought to play a crucial role in the pathophysiology of
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psoriasis [21,28]. To date, cytotoxicity studies have been
gaining importance. In this study, we detected that there
was a dose-dependent decrease in cell viability following
Salvia officinalis oil application. The optimal nontoxic
dose was statistically identified as 100 µM, and the optimal
time point was detected as 72 h. Kozics and his colleagues
examined the viability of HepG2 cells by 24-h treatment
using various concentrations of Salvia officinalis extract
as 5.7 mg-mL–1 [29]. On the other hand, Zare Shahneh
et al. applied Salvia officinalis extract on 6 different cell
lines including human breast cancer, human prostate
cancer, human leukemic monocyte lymphoma (U937),
non-Hodgkin’s B-cell lymphoma (Raji), human acute
myelocytic leukemia (KG-1A), and mouse fibrosarcoma;
they reported a range of IC50 40-167 μg mL–1 [30]. They
also stated that 200 and 300 μg/mL of Salvia officinalis
extract after incubation for 24 h was the effective dose for
Raji, U937, KG-1A, and HUVEC cell lines. In addition, El
Hadri et al. reported that Salvia officinalis showed cytotoxic
activity in murine macrophage RAW264.7 and colon
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Table 2: Significance levels (P-values) of all experimental doses.

At 24 h
25 µM
50 µM
100 µM
150 µM
200 µM
At 48 h
25 µM
50 µM
100 µM
150 µM
200 µM
At 72 h
25 µM
50 µM
100 µM
150 µM
200 µM

25 µM

50 µM

100 µM

150 µM

200 µM

0.963
0.860
0.856
0.034*

0.998
0.995
0.100

1.000
0.127

0.239

-

0.958
0.733
0.003*
0.000*

0.965
0.005*
0.001*

0.028*
0.003*

0.692

-

0.517
0.978
0.997
0.083

0.185
0.269
0.002*

0.999
0.164

0.107

-

*Significant differences: P < 0.05.

cancer at IC50 73.3 μg mL–1 [9]. Similar to our findings,
a study reported that 100 mg/mL for 24 h application of
Salvia officinalis was the most effective dose on the HepG2
cell line [6]. Additionally, a study performed by Khare et al.
evaluated the antiwrinkle potential of Salvia officinalis on
Col-I, Ela-I, and Hya-I cell lines and reported that Salvia

officinalis had inhibitory effects of antiaging enzymes by
modulating some cellular processes [31].
One limitation of this study was the lack of information
on the crucial parameters related to inflammation and
the oxidative stress processes. Experiments studying
molecular, immunological, and biochemical parameters
are needed to further elucidate this issue and to determine
the possible beneficial effects of fresh Salvia officinalis tea.
5. Conclusion
This study showed that Salvia officinalis oil used in cell
culture inhibited excessive cell proliferation via the
apoptotic pathway. We conclude that Salvia officinalis oil
may help the living organism to have a healthy digestive
system by stopping excessive cell proliferation via the
apoptotic pathway in the gastrointestinal system and, thus,
may be used in both animal feed and human nutrition.
Furthermore, Salvia officinalis oil may contribute to the
treatment of several diseases in the oral mucosa called
“tumor-like masses,” “proliferative lesions,” or “benign soft
tissue lesions,” which may lead to nutritional disorders.
In light of this information, the detailed explanation
of the underlying cellular and biochemical mechanisms
for the bioactive polyphenolic compounds of Salvia
officinalis should be developed for the successful treatment
of chronic inflammatory skin diseases such as psoriasis.
Therefore, further studies should examine the mechanisms
of antiinflammatory, antioxidant, and apoptotic effects of
Salvia officinalis extracts on different cell lines, including
HaCaT cells.
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